NanoVibronix Share Price Crosses Below Fifty Day Moving Average of 0.76 - Defense World
| NAOV Stock | USD 0.61 0.07 12.96% |
Slightly above 55% of NanoVibronix's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading NanoVibronix stock suggests that some investors are interested at this time. NanoVibronix's investing sentiment can be driven by a variety of factors including economic data, NanoVibronix's earnings reports, geopolitical events, and overall market trends.
NanoVibronix |
NanoVibronix Share Price Crosses Below Fifty Day Moving Average of 0.76 Defense World
Read at news.google.com
 |
NanoVibronix Fundamental Analysis
We analyze NanoVibronix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NanoVibronix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NanoVibronix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
NanoVibronix is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
NanoVibronix Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NanoVibronix stock to make a market-neutral strategy. Peer analysis of NanoVibronix could also be used in its relative valuation, which is a method of valuing NanoVibronix by comparing valuation metrics with similar companies.
Peers
NanoVibronix Related Equities
| BMRA | Biomerica | 16.07 | ||||
| RSLS | ReShape Lifesciences | 6.01 | ||||
| BBLG | Bone Biologics | 5.56 | ||||
| NUWE | Nuwellis | 5.50 | ||||
| IINNW | Inspira Technologies | 0.20 | ||||
| HSCS | Heart Test | 0.27 | ||||
| SSKN | STRATA Skin | 0.35 | ||||
| BJDX | Bluejay Diagnostics | 1.32 | ||||
| SINT | SINTX Technologies | 1.60 | ||||
| RPID | Rapid Micro | 3.19 | ||||
| TIVC | Tivic Health | 5.41 | ||||
| VVOS | Vivos Therapeutics | 6.05 |
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.